Dramatic reduction of liver cancer incidence in young adults: 28 Year follow-up of etiological interventions in an endemic area of China

Carcinogenesis

Volumn 34, Issue 8, 2013, Pages 1800-1805

  Sun, Zongtang ^a   Chen, Taoyang ^b   Thorgeirsson, Snorri S ^c   Zhan, Qimin ^a   Chen, Jianguo ^b   Park, Ju Hyun ^c   Lu, Peixin ^b   Hsia, Chu Chieh ^a   Wang, Nengjin ^b   Xu, Libin ^a   Lu, Lingling ^b   Huang, Fei ^b   Zhu, Yuanrong ^b   Lu, Jianhua ^b   Ni, Zhengping ^b   Zhang, Qinan ^b   Wu, Yuying ^a   Liu, Guoting ^a   Wu, Zhiyuan ^a   Qu, Chunfeng ^a   Gail, Mitchell H ^c   more..

^a CANCER HOSPITAL   (China)

^b QIDONG LIVER CANCER INSTITUTE   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ALPHA FETOPROTEIN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CHILD; CHINA; DIETARY INTAKE; ENDEMIC DISEASE; FOLLOW UP; FOOD INTAKE; HEALTH PROGRAM; HEPATITIS B; HUMAN; INCOME; INFANT; LIVER CANCER; MAIZE; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN CARE; PRIORITY JOURNAL; RICE; RISK REDUCTION; TREND STUDY; VACCINATION;

EID: 84881497702     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt007     Document Type: Article

References (30)

1. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
2. Chen, J.G., et al. (2006) Trends in the incidence of cancer in Qidong, China, 1978-2002. Int. J. Cancer, 119, 1447-1454.
3. Xia, Q.J. (aka Hsia, C.C.) et al.. (1984) Liver cell cancer in the young and adolescent and its relation to hepatitis B virus (HBV). Chin. J. Oncol., 6, 413-416.
4. Lu, J. et al. (1983) Matched prospective study of primary hepatocellular carcinoma in chronic carriers of HBsAg. Chin. J. Oncol., 5, 406-408.
5. Sun, T. et al. (1984) Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. In Mak, T.W. et al. (eds) Cellular and Molecular Biology of Neoplasia. Alan R. Liss Inc., New York, USA, pp. 39-44.
6. Ming, L. et al. (2002) Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology, 36, 1214-1220.
7. World Health Organization (1983) Prevention of liver cancer. Technical Report Series 691, World Health Organization, Geneva.
8. Zuckerman, A. et al. (1983) Prevention of primary liver cancer: report on a meeting of W.H.O. Scientific Group. Lancet, 321, 463-465.
9. Fujimoto, Y. et al. (1994) Alterations of tumor-suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res., 54, 281-285.
10. Sun, Z.T. et al. (1999) Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology, 30, 379-383.
11. Ross, R.K. et al. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
12. Hsu, I.C. et al. (1991) Mutational hotspots in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427-428.
13. Fujimoto, Y. et al. (1992) Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. Cancer Res., 52, 1044-1046.
14. Sun, Z.T. et al. (1983) Monoclonal antibody against aflatoxin B1 and its potential applications. Chin. J. Oncol., 5, 401-405.
15. Sun, Z.T. et al. (1983) Prospect of using monoclonal antibodies against aflatoxins in studying human liver carcinogenesis. Acta Acad. Med. Sinicae, 5, 344-345.
16. Wu, S. et al. (1984) Study on urinary excretion of aflatoxin M1 in Beijing and Qidong people. Chin. J. Oncol., 6, 163-167.
17. Sun, T. et al. (1986) Measurement of individual aflatoxin exposure among people having different risk to primary hepatocellular carcinoma. In Hayashi, Y. et al.. (eds) Diet, Nutrition, and Cancer: Proceedings of the 16th International Symposium of the Princess Takamatsu Cancer Research Fund. Japan Scientific Societies Press, Tokyo, Japan, pp. 225-235.
18. Sun, T. et al. (1986) A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma. In Mak, T.W. and Sun, T.-T. (eds). Cancer Perspective for Control: Proceedings of an International Symposium Held in Beijing, China, August 18-21, 1985. Alan R. Liss Inc, New York. pp. 83-90.
19. Sun, Z.T. et al. (2002) Prevention and control of hepatitis B in China. J. Med. Virol., 67, 447-450.
20. Sun, T. et al. (1986) Strategies and current trends of etiological prevention of liver cancer. In Harris, C.C. (ed). Biochemical and Molecular Epidemiology of Cancer. Alan R. Liss Inc, New York, USA, pp. 283-292.
21. Parkin, D.M. et al. (2002) Cancer incidence in ?ve continents, VIII. IARC Sci. Publ. No. 155. IARC, Lyon, pp. 212-231.
22. Ferlay, J. et al. (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10. International Agency for Research on Cancer; Year, Lyon, France. http://globocan.iarc.fr (17 August 2010, date last accessed).
23. Perz, J.F. et al. (2006) The contribution of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatology, 45, 529-538.
24. Okuda, K. et al. (2002) Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J. Gastroenterol. Hepatol., 17, 1049-1055.
25. Altekruse, S.F. et al. (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J. Clin. Oncol., 27, 1485-1491.
26. Chang, M.H. et al. (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J. Natl. Cancer Inst., 101, 1348-1355.
27. Jin, F. et al. (1999) Cancer incidence trends in urban Shanghai, 1972-1994: an update. Int J. Cancer, 83, 435-440.
28. Hao, X.S. et al. (2003) Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population. Eur. J. Cancer Prev., 12, 273-279.
29. Guo, P. et al. (2012) Trends in cancer mortality in China: an update. Ann. Oncol., 23, 2755-2762.
30. El-Serag, H.B. (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatol. Res., 37 (suppl. 2), S88-S94.